All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 42 of 206 pages ‹ First < 40 41 42 43 44 > Last ›
HSL14890
Thomaselli R.
'Morning-After Pill' Catches Flak for MTV.com Ad
The Advertising Adage 2009 Jan 8
http://adage.com/article?article_id=133632
HSL14891
Connolly C.
With More Oversight on the Horizon, Drugmakers Work to Polish Image
The Washington Post 2009 Jan 8
http://www.washingtonpost.com/wp-dyn/content/article/2009/01/07/AR2009010703869.html
HSL14913
Herper M.
The Value Of New Drugs Is Dropping
Forbes.com 2009 Jan 8
http://www.forbes.com/2009/01/07/pharmaceuticals-sales-biz-healthcare-cx_mh_0108drugssales.html
HSL14914
Rubenstein S.
Drug Industry Hustles to Blunt Democratic Strikes
The Wall Street Journal Blog 2009 Jan 8
http://blogs.wsj.com/health/2009/01/08/drug-industry-hustles-to-blunt-democratic-strikes/
HSL14924
Sweney M.
Sex drug poster ads to be taken down
Guardian.co.uk 2009 Jan 8
http://www.guardian.co.uk/media/2009/jan/08/sex-drug-ads-taken-down
HSL14960
Monash D.
Time to put pharmacists under the microscope
Crikey 2009 Jan 8
http://www.crikey.com.au/Politics/20090108-Why-its-time-to-put-pharmacy-under-scrutiny.html
HSL14900
Hirji KF.
No short-cut in assessing trial quality: a case study.
Trials 2009 Jan 7;10:(1):
www.trialsjournal.com/content/10/1/1
HSL14901
Gøtzsche PC.
Readers as research detectives
Trials 2009 Jan 7;10:(1):
www.trialsjournal.com/content/10/1/2
HSL14915
Hopkins Tanne J.
US university psychiatrist loses chairmanship over drug company payments..
BMJ. 2009 Jan 6;338:a3188:
http://www.bmj.com/cgi/content/extract/338/jan05_3/a3188
HSL14880
Taylor L.
German govt 'to force drugmakers to sell through wholesalers'
Pharma Times 2009 Jan 5
http://www.pharmatimes.com/WorldNews/article.aspx?id=15023&src=EWorldNews
HSL14881
Stepping into the therapeutics void.
Coombes R.
BMJ. 2009 Jan 5;338:a3179:
http://www.bmj.com/cgi/content/full/338/jan05_2/a3179
HSL14882
Pharmaceutical Research and Manufacturers of America Enacts New Voluntary Guidelines on Physician Gifting Practices
Kaiser Daily Health Policy Report. 2009 Jan 5
http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=56245
HSL14885
Change in FDA's ethical guidelines for clinical trials troubling: Lancet
CBC News 2009 Jan 5
http://www.cbc.ca/health/story/2009/01/05/fda.html
HSL14910
Coombes R.
Stepping into the therapeutics void.
BMJ. 2009 Jan 5;338:a3179:
http://www.bmj.com/cgi/content/extract/338/jan05_2/a3179
HSL14916
New Year Resolution: Stand Up to Healthcare Marketing Hypocrisy!
Trusted.MD 2009 Jan 5
http://trusted.md/blog/hippocrates/2009/01/06/new_year_resolution_stand_up_to_healthcare_marketing_hypocrisy
HSL14918
Staton T.
Shrinking sales forces face constraints
Fierce Pharma 2009 Jan 5
http://www.fiercepharma.com/story/shrinking-sales-forces-face-constraints/2009-01-03
HSL14919
Staton T.
Congress mandates disclosure
Fierce Pharma 2009 Jan 5
http://www.fiercepharma.com/story/show-us-yours-well-show-you-ours/2009-01-03
HSL14883
No Mugs, but What About Those Fees
The New York Times 2009 Jan 4
http://www.nytimes.com/2009/01/05/opinion/05mon1.html
HSL17010
Silverman E
Drugging Kids for Profit
Portfolio.com 2009 Jan 4
http://www.portfolio.com/industry-news/health-care/2010/01/04/drugging-kids-for-profit/index1.html
HSL14909
Tyrer P, Kendall T.
The spurious advance of antipsychotic drug therapy
The Lancet 2009 Jan 3;373:(9657):4-5
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)61765-1/fulltext
HSL14911
Kimmelman J, Weijer C, Meslin EM.
Helsinki discords: FDA, ethics, and international drug trials
The Lancet 2009 Jan 3;373:(9657):13-4
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)61936-4/fulltext
HSL14869
Pringle E.
SSRI Pushers under Fire
Scoop 2009 Jan 2
http://www.scoop.co.nz/stories/HL0901/S00008.htm
HSL14917
AMSA Applauds Pharma Ban; Continues to Call for Federal Regulation
Pharma Live 2009 Jan 2
http://pharmalive.com/news/index.cfm?articleID=595275
HSL18635
Dantzer S
Perspective: Communicating Medical News—Pitfalls of Health Care Journalism
New England Journal of Medicine 2009 Jan 1;360:1- 3
http://www.nejm.org/doi/full/10.1056/NEJMp0805753
HSL14841
Poole D, Bertolini G, Garattini S.
Errors in the approval process and post-marketing evaluation of drotrecogin alfa (activated) for the treatment of severe sepsis.
Lancet Infect Dis 2009 Jan;9:(1):67-72
http://linkinghub.elsevier.com/retrieve/pii/S1473-3099(08)70306-2
HSL14893
Kyle GJ, Nissen LM, Tett SE
The Australian rise of esomeprazole-was expenditure on samples a contributor?
Pharmacoepidemiol Drug Saf. 2009 Jan;18:(1):62-8
http://www3.interscience.wiley.com/journal/121587742/abstract?CRETRY=1&SRETRY=0
HSL14907
Clauson KA, Khanfar NM, Polen HH, Gibson F.
Nurse prescribers' interactions with and perceptions of pharmaceutical sales representatives.
J Clin Nurs 2009 Jan;18:(2):228-33
http://www3.interscience.wiley.com/journal/121562111/abstract
HSL15001
Levinson DR
The Food and Drug Administration’s Oversight of Clinical Investigator’s Financial Information
: FDA 2009 Jan
http://www.oig.hhs.gov/oei/reports/oei-05-07-00730.pdf
HSL15017
Thawani V, Gharpure K.
Monitoring misuse of the WHO name and emblem in medicine promotion in India
Indian Journal of Medical Ethics 2009 Jan-Mar;17:(1):epub
http://www.ijme.in/171ar10
HSL15048
Klemperer D.
[Self-help groups conflicts of interest through sponsoring by the pharmaceutical industry].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2009 Jan;52:(1):71-6
http://www.springerlink.com/content/92x3337327075725/
HSL15054
Shankar PR, Piryani RM
Medical education and medical educators in South Asia - a set of challenges.
J Coll Physicians Surg Pak. 2009 Jan;19:(1):52-6
http://www.ncbi.nlm.nih.gov/pubmed/19149982
HSL15234
Spake DF, Joseph M, Finney RZ.
Urban senior citizens' versus rural consumers' views of DTC advertising: A preliminary investigation
Journal of Medical Marketing 2009 Jan;9:(1):21–28
http://www.palgrave-journals.com/jmm/journal/v9/n1/abs/jmm200817a.html
HSL15235
Kelly D, Rupert E.
Professional emotions and persuasion: Tapping non-rational drivers in health-care market research
Journal of Medical Marketing 2009 Jan;9:(1):3–9
http://www.palgrave-journals.com/jmm/journal/v9/n1/abs/jmm200828a.html
HSL15322
Joseph JN, Deaton D, Ehsan H, Bonanno MA
Enforcement related to off-label marketing and use of drugs and devices: where have we been and where are we going?
J Health Life Sci Law 2009 Jan;2:(2):73-108
http://www.ncbi.nlm.nih.gov/pubmed/19288889
HSL15439
Hall J, Noyce P, Cantrill JHow do district nurses choose which products to prescribe.
How do district nurses choose which products to prescribe?
Br J Community Nurs. 2009 Jan;14:(1):12,
http://www.ncbi.nlm.nih.gov/pubmed/19363864
HSL17087
Heinemann L.
Trust: Need for an Improved Communication between the Public World and the Pharmaceutical Companies.
J Diabetes Sci Technol 2009 Jan;3:(1):210-2
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769856/?tool=pubmed
HSL19336
Stossel TP.
AACE and ACRE: Harmony of Interests.
Endocr Pract 2009;15:(7):671
http://aace.metapress.com/content/9672618x727134v6/
HSL19027
Barry DA, Baines CJ, Baum M, Dickersin K, Fletcher SW, Gøtzsche PC, Jørgensen KJ, Junod B, Maehlen J, Schwartz LM, Welch HG, Woloshin S, Thornton H, Zahl PH.
Flawed inferences about screening mammography's benefit based on observational data.
J Clin Oncol 2009 1;27:(4):639-40
http://jco.ascopubs.org/content/27/4/639.long
HSL19330
Rose L, Garrow J.
False claims in health care: outlawed at last?
Med Leg J 2009;77:(Pt 2):66-8.
http://mlj.rsmjournals.com/
HSL19023
Woloshin S, Schwartz LM, Kramer BS.
Promoting healthy skepticism in the news: helping journalists get it right.
Natl Cancer Inst 2009 2;101:(23):1596-9
http://jnci.oxfordjournals.org/content/101/23/1596.long
HSL14552
Global pharma market forecast to exceed $820bn in 2009
Manufacturing Chemist 2009
http://www.ims-japan.co.jp/pr_20081029.php
HSL14929
Tattersall MHN, Dimoska A, Gan K.
Patients expect transparency in doctors’ relationships with the pharmaceutical industry
eMJA 2009;2:65-68
http://www.mja.com.au/public/issues/190_02_190109/tat10368_fm.html
HSL14930
Olver IN, Haines IE.
What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?
eMJA 2009;190:(2):74-77
http://www.mja.com.au/public/issues/190_02_190109/olv10224_fm.html
HSL14946
Loukas E.
Sales Through Retail Pharmacies (Twelve months to November 2008*)
IMS 2009
http://view.respond.imshealth.com/?j=fe8a12757c66067471&m=fef31377726304&ls=fdf51577706d027d77137070&l=fe9c1570746204787
HSL14991
Sweet M.
Pharmaceutical marketing and the internet
Australian Prescriber 2009;23:2-4
http://www.australianprescriber.com/magazine/32/1/2/4/
HSL15040
Stockigt JR.
The quality of medication information in Australia: the need for more clinical expertise and accountability
eMJA 2009;190:(3):110-111
http://www.mja.com.au/public/issues/190_03_020209/sto11172_fm.html
HSL15045
Mansell P, Read J.
Posttraumatic stress disorder, drug companies, and the internet.
J Trauma Dissociation 2009;10:(1):9-23
http://www.ncbi.nlm.nih.gov/pubmed/19197709
HSL15046
Alkhateeb FM, Khanfar NM, Clauson KA.
Characteristics of physicians who frequently see pharmaceutical sales representatives.
J Hosp Mark Public Relations 2009;19:(1):2-14
http://www.ncbi.nlm.nih.gov/pubmed/19197653
HSL15047
Polen HH, Khanfar NM, Clauson KA.
Impact of Direct-to-Consumer Advertising (DTCA) on Patient Health-Related Behaviors and Issues.
Health Mark Q. 2009;26:(1):42-55
http://www.ncbi.nlm.nih.gov/pubmed/19197587
HSL15165
Elshaug AG, Moss JR, Littlejohns P, Karnon J, Merlin TL, Hiller JE.
Identifying existing health care services that do not provide value for money
Med J Aust 2009;190:(5):269-273
http://www.mja.com.au/public/issues/190_05_020309/ell10663_fm.html
HSL15177
PriceWaterhouseCoopers
Pharma 2020: Marketing the future: Which path will you take?
: PriceWaterhouseCoopers 2009
http://www.pwc.com/Extweb/pwcpublications.nsf/docid/B1221EC9D057309F852575610076732C
HSL15182
Aronson JK, Price D, Ferner RE
A strategy for regulatory action when new adverse effects of a licensed product emerge.
Drug Saf 2009;32:(2):91-8
http://www.ncbi.nlm.nih.gov/pubmed/19236116?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
HSL15262
Leo J, Lacasse JR.
Consumer advertisements of medications for ADHD
Tamimi S, Leo J. Rethinking ADD: From Brain To Culture. New York: Palgrave Macmillan 2009
http://www.amazon.com/Rethinking-ADHD-Culture-Sami-Timimi/dp/0230507123
HSL15382
Abelson J, Collins PA.
Media Hyping and the 'Herceptin Access Story': An Analysis of Canadian and UK Newspaper Coverage
Healthcare Policy / Politiques de Santé 2009;4:(3):e113-e128
http://www.longwoods.com/product.php?productid=20474&cat=582
HSL15505
Mulki JP, Jaramillo JF, Locander WB.
Critical Role of Leadership on Ethical Climate and Salesperson Behaviors
Journal of Business Ethics 2009;(86):125-141
http://www.springerlink.com/content/355705k570264364/
HSL15524
Jureidini J
How do we Safely Treat Depression in Children, Adolescents and Young Adults?
Drug Saf 2009;32:(4):275-82
http://www.ncbi.nlm.nih.gov/pubmed/19388719
HSL15541
Rod M, Saunders S.
The informative and persuasive components of pharmaceutical
International Journal of Advertising 2009;28:(2):313-349
http://www.internationaljournalofadvertising.com/
HSL15568
Manhattan Research
The Absolute, Relative, and Incremental ROI of DTC Digital Marketing
: Manhattan Research 2009
http://www.manhattanresearch.com/files/White_Papers/The_Absolute_Relative_and_Incremental_ROI_of_DTC_Digital_Marketing.pdf
HSL15625
Molnar FJ, Man-son-hing M, Hutton B, Fergusson DA.
Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review
Open Medicine 2009;3:(2):
http://www.openmedicine.ca/article/view/245/230
HSL15626
Altman DG.
Missing outcomes in randomized trials: addressing the dilemma
Open Medicine 2009;3:(2):
http://www.openmedicine.ca/article/view/323/232
HSL15635
Food and Drug Administration
RE: NDA #20-449 Taxotere® (docetaxel) Injection Concentrate, Intravenous Infusion (IV)
: Food and Drug Administration 2009
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM153134.pdf
HSL15700
Jureidini JN, McHenry LB.
Key Opinion Leaders and Paediatric Antidepressant Overprescribing
Psychotherapy and Psychosomatics 2009;78:(4):197-201
http://www.online.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=214440&Ausgabe=248735&ProduktNr=223864&filename=214440.pdf
HSL15785
Vandereycken W.
[An analysis of advertisements for psychotropic drugs in the Dutch Journal of Psychiatry ('Tijdschrift voor Psychiatrie')].
Tijdschr Psychiatr. 2009;51:(6):407-11
http://www.tijdschriftvoorpsychiatrie.nl/en/tijdschrift/artikel/TVPart_2796
HSL15786
Greene JA, Podolsky SH
Keeping modern in medicine: pharmaceutical promotion and physician education in postwar america.
Bull Hist Med 2009;83:(2):331-77
http://muse.jhu.edu/journals/bulletin_of_the_history_of_medicine/v083/83.2.greene.html
HSL15834
Liang BA, Mackey T.
Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales.
Am J Law Med. 2009;35:(1):125-84
http://www.ncbi.nlm.nih.gov/pubmed/19534258
HSL15881
Rojas M.
Price discrimination by pharmaceutical companies across Central American countries
International Journal of Pharmaceutical and Healthcare Marketing 2009;3:(2):118 - 136
http://www.emeraldinsight.com/Insight/viewContentItem.do?contentType=Article&contentId=1796048
HSL15882
Kalyanaram GK.
The endogenous modeling of the effect of direct-to-consumer advertising in prescription drugs
International Journal of Pharmaceutical and Healthcare Marketing 2009;3:(2):137 - 148
http://www.emeraldinsight.com/Insight/viewContentItem.do?contentType=Article&contentId=1796049
HSL15963
Greenland S.
Accounting for uncertainty about investigator bias: disclosure is informative: How could disclosure of interests work better in medicine, epidemiology and public health?
Journal of Epidemiology and Community Health 2009;63:593-598
http://jech.bmj.com/cgi/content/extract/63/8/593?etoc
HSL15964
Michaels D.
Addressing conflict in strategic literature reviews: disclosure is not enough: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009;63:599-600
http://jech.bmj.com/cgi/content/extract/63/8/599?etoc
HSL15965
Weed DL.
Conflicts of interest: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009;63:(8):601-602
http://jech.bmj.com/cgi/content/extract/63/8/601?etoc
HSL15966
Spelsberg A, Martiny A, Schoenhoefer PS.
Is disclosure of potential conflicts of interest in medicine and public health sufficient to increase transparency and decrease corruption?: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009;63:(8):603-605
http://jech.bmj.com/cgi/content/extract/63/8/603?etoc
HSL15967
Wagner W, McGarity T.
Regulatory reinforcement of journal conflict of interest disclosures: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009;63:(8):606-607
http://jech.bmj.com/cgi/content/extract/63/8/606?etoc
HSL15968
Marcovitch H.
How do potential conflicts of interest confuse medicine and public health? How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009;63:(8):608-609
http://jech.bmj.com/cgi/content/extract/63/8/608?etoc
HSL15970
12th Annual Survey on Consumer Reaction to DTC Advertising of Prescription Drugs Reveals: Nearly 50% of Online Consumers Report Health Videos a Top Resource
Pharma Live 2009
http://pharmalive.com/news/index.cfm?articleID=638484
HSL15987
Bove AA.
President's Page: Relations With Industry: Thoughts on Claims of a Broken System
J Am Coll Cardiol 2009;54:(2):177-179
http://content.onlinejacc.org/cgi/content/full/54/2/177
HSL16018
O'Meara A.
Chasing Medical Miracles - The Promise and Perils of Clinical Trials
: Walker Books 2009
http://www.walkerbooks.com/books/catalog.php?key=818
HSL16023
Glasziou PP.
Promoting evidence-based non-drug interventions: time for a non-pharmacopoeia?
MJA 2009;191:(2):52-53
http://www.mja.com.au/public/issues/191_02_200709/gla10407_fm.html
HSL16024
Lexchin J.
CJEM and pharmaceutical advertisements: it’s time for an end
CJEM 2009;11:(4):375-9
http://www.cjem-online.ca/v11/n4/p375
HSL16080
Limbu Y, Torres IM.
The effects of involvement and ad type on attitudes toward direct-to-consumer advertising of prescription drugs.
J Health Hum Serv Adm 2009 Sum;32:(1):107-38
http://www.ncbi.nlm.nih.gov/pubmed/19558035
HSL16098
Rutherford BR, Sneed JR, Roose SP.
Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials.
Psychother Psychosom 2009;78:(3):172-81
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=000209348
HSL16100
Kale SA, Barkin RL.
Resuscitation and rescue of the pharmaceutical detail: a prescriber-drug representative collaboration.
Compr Ther 2009 Sum;35:(2):68-71
http://www.ncbi.nlm.nih.gov/pubmed/19618754
HSL16164
Martin JH, Beer C, Morris RG, Doogue MP.
Doctors and the pharmaceutical industry: time for a national policy?
MJA 2009;191:(3):189-190
http://www.mja.com.au/public/issues/191_03_030809/letters_030809_fm-4.html
HSL16254
Taylor D
Branding Q&A
MedAdNews 2009
http://medad.canon-experts.com/expert/dale-taylor/
HSL16285
Wyeth Ghostwriting Archive
PLoS Med 2009;
http://www.plosmedicine.org/static/ghostwriting.action
HSL16459
Gérvas J, Mansfield PR
Physicians, the industry and population health
Journal of Epidemiology and Community Health 2009;63:(10):773-774
http://jech.bmj.com/cgi/content/extract/63/10/773
HSL16469
Van Der Weyden MB
Confronting conflict of interest
eMJA 2009;191:(5):241
http://www.mja.com.au/public/issues/191_05_070909/martin_070909.html
HSL16529
Gülöksüz S, Oral ET, Ulaş H.
[Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
Turk Psikiyatri Derg 2009;20:(3):236-42
http://www.turkpsikiyatri.com/ftr.aspx?id=714
HSL16557
Tipton M, Bharadwaj S, Robertson D
Regulatory Exposure of Deceptive Marketing and its Impact on Firm Value
Journal of Marketing 2009;
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1431978
HSL16669
Kalb PE, Greenberg PE.
Legal and economic perspectives concerning US government investigations of alleged off-label promotion by drug manufacturers.
Pharmacoeconomics 2009;27:(8):623-5
http://www.ncbi.nlm.nih.gov/pubmed/19835018
HSL16758
Egilman D
Just say no
BMJ 2009;339:b4527
http://www.bmj.com/cgi/content/short/339/nov02_2/b4527?rss=1
HSL16769
Zinner DE, Bjankovic D, Clarridge B, Blumenthal D, Campbell EG
Participation Of Academic Scientists In Relationships With Industry
Health Affairs 2009;28:(6):1814
http://content.healthaffairs.org/cgi/content/abstract/28/6/1814
HSL16810
Evidence and Recommendations for a Model PharmFree Curriculum
PharmFree 2009
http://www.pharmfree.org/tools/resources_documents/files/ModelPharmFreeCurriculum_Final.pdf
HSL16863
de Barros JA
Medicamentos: una contribución a la reflexión hacia su uso racional
RISAI 2009;1:(3):1-5
http://pub.bsalut.net/cgi/viewcontent.cgi?article=1027&context=risai
HSL16887
Ghaemi SN
The failure to know what isn't known: negative publication bias with lamotrigine and a glimpse inside peer review
Evid Based Mental Health 2009;12:(3):65
http://ebmh.bmj.com/content/12/3/65.full
HSL16925
The Royal Australian and New Zealand College of Psychiatrists
Symposium on Commercial Sponsorship of Psychiatrist Education
2009
http://ranzcp.cmsaustralasia.com/video.load.php?videosource=rtmp://ocy932wr.rtmphost.com/09175/Panel_LR.FLV
HSL16933
Sweet MA, Simons MJ
As mass media evolves into 'masses of media', what are the implications for our health?
Med J Aust 2009;191:(11/12):618-619
http://www.mja.com.au/public/issues/191_11_071209/swe11253_fm.html
HSL16934
Chapman S, Holding SJ, Ellerm J, Heenan RC, Fogarty AS, Imison M, Mackenzie R, McGeechan K
The content and structure of Australian television reportage on health and medicine, 2005-2009: parameters to guide health workers
Med J Aust 2009;191:(11/12):620-624
http://www.mja.com.au/public/issues/191_11_071209/cha10706_fm.html
HSL16935
Medicines Australia Code of Conduct: breaches
Aust Prescr 2009
http://www.australianprescriber.com/magazine/32/6/160/1/
HSL16937
Archontaki M, Symvoulakis EK, Hajiioannou JK, Stamou AK, Kastrinakis S, Bizaki AJ, Kyrmizakis DE.
Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants.
B-ENT 2009;5:(3):159-62
http://www.ncbi.nlm.nih.gov/pubmed/19902852
HSL17018
Sismondo S, Nicholson SH.
Publication planning 101.
J Pharm Pharm Sci 2009;12:(3):273-9
http://ejournals.library.ualberta.ca/index.php/JPPS/article/viewFile/6299/5594
Page 42 of 206 pages ‹ First < 40 41 42 43 44 > Last ›
